Repression of E1AF transcriptional activity by sumoylation and PIASy

Biochemical and Biophysical Research Communications

Volumn 360, Issue 1, 2007, Pages 226-232

  Nishida, Tamotsu ^a   Terashima, Motoko ^b   Fukami, Kiyoko ^b   Yamada, Yoshiji ^a  

^a MIE UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

E1AF; Ets; PEA3; PIAS; PIASy; SUMO; SUMO 1; SUMO E3 ligase

Indexed keywords

ARGININE; ENZYME; LYSINE; MUTANT PROTEIN; PROTEIN E1AF; PROTEIN INHIBITOR OF ACTIVATED STAT; SUMO E3 LIGASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SUMOYLATION;

ADENOVIRUS E1A PROTEINS; HUMANS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); UBIQUITIN;

EID: 34250875087     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.037     Document Type: Article

References (34)

1. Hay R.T. SUMO: A history of modification. Mol. Cell 18 (2005) 1-12
2. Gill G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 13 (2005) 108-113
3. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15 (2005) 536-541
4. Hochstrasser M. SP-RING for SUMO: New functions bloom for a ubiquitin-like protein. Cell 107 (2001) 5-8
5. Johnson E.S., and Gupta A.A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106 (2001) 735-744
6. Kahyo T., Nishida T., and Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8 (2001) 713-718
7. Takahashi Y., and Kahyo T. A. Toh-E, H. Yasuda, Y. Kikuchi, Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J. Biol. Chem. 276 (2001) 48973-48977
8. Graves B.J., and Petersen J.M. Specificity within the ETS family of transcription factors. Adv. Cancer Res. 75 (1998) 1-55
9. Seth A., Ascione R., Fisher R.J., Mavrothalassitis G.J., Bhat N.K., and Papas T.S. The ETS gene family. Cell Growth & Differ. 3 (1992) 327-334
10. Janknecht R., and Nordheim A. Gene regulation by Ets proteins. Biochim. Biophys. Acta 1155 (1993) 346-356
11. Wasylyk B., Hahn S.L., and Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211 (1993) 7-18
12. Yang S.H., Jaffray E., Hay R.T., and Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12 (2003) 63-74
13. Salinas S., Briancon-Marjollet A., Bossis G., Lopez M.A., Piechaczyk M., Jariel-Encontre I., Debant A., and Hipskind R.A. SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1. J. Cell Biol. 165 (2004) 767-773
14. Chakrabarti S.R., Sood R., Nandi S., and Nucifora G. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. USA 97 (2000) 13281-13285
15. Wood L.D., Irvin B.J., Nucifora G., Luce K.S., and Hiebert S.W. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl. Acad. Sci. USA 100 (2003) 3257-3262
16. Nishida T., Terashima M., and Fukami K. PIASy-mediated repression of the Ets-1 is independent of its sumoylation. Biochem. Biophys. Res. Commun. 345 (2006) 1536-1546
17. Higashino F., Yoshida K., Fujinaga Y., Kamio K., and Fijinaga K. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: A new human member of the ETS oncogene family. Nucleic Acids Res. 21 (1993) 547-553
18. Xin J.-H., Cowie A., Lachance P., and Hassell J.A. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6 (1992) 481-496
19. de Launoit Y., Baert J.L., Chotteau A., Monte D., Defossez P.A., Coutte L., Pelczar H., and Leenders F. Structure-function relationships of the PEA3 group of Ets-related transcription factors. Biochem. Mol. Med. 61 (1997) 127-135
20. Kaya M., Yoshida K., Higashino F., Mitaka T., Ishii S., and Fujinaga K. A single ETS-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 12 (1996) 221-227
21. Shepherd T.G., Kockeritz L., Szrajber M.R., Muller W.J., and Hassell J.A. The pea3 subfamily ETS genes are required for HER2/Neu-mediated mammary oncogenesis. Curr. Biol. 11 (2001) 1739-1748
22. Kurpios N.A., Sabolic N.A., Shepherd T.G., Fidalgo G.M., and Hassell J.A. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 8 (2003) 177-190
23. Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M., Hida K., Kohgo T., Amemiya A., Yoshida K., and Fujinaga K. Correlated expression of matrix metalloproteinases and ETS family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am. J. Pathol. 148 (1996) 693-700
24. Higashino F., Yoshida K., Noumi T., Seiki M., and Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10 (1995) 1461-1463
25. Shindoh M., Higashino F., and Kohgo T. E1AF, an ETS-oncogene family transcription factor. Cancer Letters 216 (2004) 1-8
26. Degerny C., Monte D., Beaudoin C., Jaffray E., Portois L., Hay R.T., de Launoit Y., and Baert J.-L. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J. Biol. Chem. 280 (2005) 24330-24338
27. Rodriguez M.S., Dargemont C., and Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol. Chem. 276 (2001) 12654-12659
28. Crawford H.C., Fingleton B., Gustavson M.D., Kurpios N., Wagenaar R.A., Hassell J.A., and Matrisian L.M. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell Biol. 21 (2001) 1370-1383
29. Takahashi A., Higashino F., Aoyagi M., Yoshida K., Itoh M., Kobayashi M., Totsuka Y., Kohgo T., and Shindoh M. E1AF degradation by a ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 327 (2005) 575-580
30. Desterro J.M., Rodriguez M.S., and Hay R.T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2 (1998) 233-239
31. Bies J., Markus J., and Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277 (2002) 8999-9009
32. Schmidt D., and Muller S. PIAS/SUMO: New partners in transcriptional regulation. Cell. Mol. Life Sci. 60 (2003) 2561-2574
33. Sharrocks A.D. PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases?. Genes Dev. 20 (2006) 754-758
34. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., and Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15 (2001) 3088-3103